MacroGenics | MGNX - Le Chiffre D'Affaires De Vente

Prix De L'Action
2.86
Variation Quotidienne
-0.04 -1.38%
Mensuellement
63.43%
Annuel
43.36%
Q1 Prévisions
2.77




Ventes Changement Date
AbbVie USD 16.62B 840M 2025-12
Amgen USD 9.9B 340M 2025-12
AstraZeneca USD 15.5B 313M 2025-12
Biogen USD 2.28B 250M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Daiichi Sankyo JPY 558.11B 57.35B 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Genmab DKK 1.06B 36M 2025-12
Geron USD 48.02M 820K 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
J&J USD 24.6B 610M 2025-12
Karyopharm Therapeutics USD 30.54M 8.24M 2024-12
MacroGenics USD 41.23M 31.61M 2025-12
Merck USD 16.4B 880M 2025-12
Pfizer USD 17.58B 880M 2025-12
Puma Biotechnology USD 80.54M 33.46M 2024-09
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Xencor USD 28.24M 7.24M 2025-12